Overview

Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
A 12-week evaluation of the safety and efficacy of dapsone gel 5% when used with tretinoin gel 0.025% compared with tretinoin gel 0.025% monotherapy in treating moderate to severe facial acne vulgaris
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Dapsone
Tretinoin